- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01582126
Group Balance Training for People With Multiple Sclerosis
March 26, 2015 updated by: Anette Forsberg, PhD, Örebro County Council
People with multiple sclerosis (MS) often have affected balance capacity and an increased risk for falls.
A risk factor for falls are activities requiring dual attention.
Another factor leading to reduced balance capacity is trunk stability, and decreased trunk stability has been seen in people with MS compared to healthy controls.
Earlier studies using core stability exercises have shown positive effects on balance, compared to no training.
In Sweden, physical therapy for people with MS has often included group training.
However, evidence for this intervention is scarce.
The aim of this study is therefore to investigate balance training in group.
The balance training includes core stability exercises and dual attention activities.
A multi-centre study is planned with a waiting-list design.
Participants are randomised to either exercise group with early start or with late start.
The group balance training includes training 60 minutes 2 times per week for 7 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
87
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Eskilstuna, Sweden, 63188
- Mälarsjukhuset
-
Karlstad, Sweden
- Karlstad hospital
-
Linköping, Sweden
- Rörelse och hälsa neuro
-
Mjölby, Sweden
- Primärvård Mjölby
-
Nyköping, Sweden
- Nyköpings hospital
-
Västerås, Sweden, 72189
- Västerås Hospital
-
Örebro, Sweden, 70185
- University Hospital Örebro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosed multiple sclerosis by a neurologist, being able to walk 100 m with or without walking device, being able to get down on the floor with minor assistance
Exclusion Criteria:
- No balance deficit here defined as being able to stand still heel-toe for 30 seconds with arms crossed.
- Ongoing relapse, cognitive- or language difficulties that prohibits performing the outcome measures.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group balance training early start
|
Balance training i group with focus on core stability exercises and dual attention activities.
|
|
Experimental: Group balance training late start
|
Balance training i group with focus on core stability exercises and dual attention activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in Bergs balance scale
Time Frame: Change from Baseline in Bergs balance scale at 7 weeks
|
Functional balance scale in sitting, standing and walking.
|
Change from Baseline in Bergs balance scale at 7 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in Four Square step test
Time Frame: Change from Baseline in Four Square step test at 7 weeks
|
Dynamic balance
|
Change from Baseline in Four Square step test at 7 weeks
|
|
Change from baseline in Timed chair stands test
Time Frame: Change from baseline in Times Chair stands test at 7 weeks
|
Functional leg strength, rising 10 times from a chair.
|
Change from baseline in Times Chair stands test at 7 weeks
|
|
Change from baseline in Timed Up and Go test
Time Frame: Change from baseline in Timed Up and Go test at 7 weeks
|
Functional mobility.
|
Change from baseline in Timed Up and Go test at 7 weeks
|
|
Change from baseline in Functional Gait Assessment
Time Frame: Change from baseline in Functional Gait Assessment at 7 weeks
|
Gait-related activities
|
Change from baseline in Functional Gait Assessment at 7 weeks
|
|
Change from baseline in Postural sway
Time Frame: Change from baseline in Postural sway at 7 weeks
|
Using a sway meter postural sway in standing still is assessed.
|
Change from baseline in Postural sway at 7 weeks
|
|
Change from baseline in Activities-specific Balance scale
Time Frame: Change from baseline in Activities-specific Balance scale at 7 weeks
|
16 item questionnaire that includes items on balance self-efficacy
|
Change from baseline in Activities-specific Balance scale at 7 weeks
|
|
Change from baseline in 12-item Multiple Sclerosis Walking scale
Time Frame: Change from baseline in 12-item Multiple Sclerosis Walking scale at 7 weeks
|
self-reported limitations in walking.
|
Change from baseline in 12-item Multiple Sclerosis Walking scale at 7 weeks
|
|
Change from Baseline in Bergs balance scale
Time Frame: Change from Baseline in Bergs balance scale at 14 weeks
|
Functional balance in sitting, standing and walking
|
Change from Baseline in Bergs balance scale at 14 weeks
|
|
Change from Baseline in Four Square step test
Time Frame: Change from baseline in Four Square step test at 14 weeks
|
Dynamic balance
|
Change from baseline in Four Square step test at 14 weeks
|
|
Change from baseline in Times Chair stands test
Time Frame: Change from baseline in Times Chair stands test at 14 weeks
|
Functional lower extremity strength
|
Change from baseline in Times Chair stands test at 14 weeks
|
|
Change from baseline in Timed Up and Go test
Time Frame: Change from baseline in Timed Up and Go test at 14 weeks
|
Functional mobility
|
Change from baseline in Timed Up and Go test at 14 weeks
|
|
Change from baseline in Functional Gait Assessment
Time Frame: Change from baseline in Functional Gait Assessment at 14 weeks
|
Gait-related activities
|
Change from baseline in Functional Gait Assessment at 14 weeks
|
|
Change from baseline in postoral sway
Time Frame: Change from baseline in postoral sway at 14 weeks
|
Using a sway meter postural sway in standing still is assessed.
|
Change from baseline in postoral sway at 14 weeks
|
|
Change from baseline in Activities-specific Balance scale
Time Frame: Change from baseline in Activities-specific Balance scale at 14 weeks
|
Balance self-efficacy
|
Change from baseline in Activities-specific Balance scale at 14 weeks
|
|
Change from baseline in 12-item Multiple Sclerosis Walking scale
Time Frame: Change from baseline in 12-item Multiple Sclerosis Walking scale at 14 weeks
|
self-reported limitations in walking
|
Change from baseline in 12-item Multiple Sclerosis Walking scale at 14 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Anette Forsberg, PhD, Family Medicine Research Centre, Örebro County Council
- Principal Investigator: Ylva Nilsagård, PhD, Centre for Health Care Sciences, Örebro County Council
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
April 16, 2012
First Submitted That Met QC Criteria
April 19, 2012
First Posted (Estimate)
April 20, 2012
Study Record Updates
Last Update Posted (Estimate)
March 27, 2015
Last Update Submitted That Met QC Criteria
March 26, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ö-1-12
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Group balance training
-
RehaClinic AGCompleted
-
Foundation University IslamabadRecruitingCognitive Dysfunction | Elderly PopulationPakistan
-
Ibadat International University, IslamabadRecruitingAthletic Performance | Postural Balance | Dynamic StabilityPakistan
-
Hacettepe UniversityUnknown
-
Riphah International UniversityNot yet recruitingOsteoporosis PostmenopausalPakistan
-
Maharishi Markendeswar University (Deemed to be...Completed
-
Riphah International UniversityNot yet recruiting
-
Riphah International UniversityCompleted
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway